Literature DB >> 7118162

Enhancement of sheep erythrocyte (SRBC)-induced pleurisy in non-sensitized mice by cyclophosphamide: demonstration of natural cell-mediated immune reactivity to SRBC.

S Yamamoto, Y Higuchi, H Teshima.   

Abstract

Intrapleural injection of 2 x 10(8) sheep erythrocytes (SRBC) into normal C57BL/6N (B6) mice produced a low but significant exudate leucocyte reaction, which was delayed in onset and mononuclear cell dominant. However, administration of 20-200 mg/kg cyclophosphamide (CY) in mice induced a dose-dependent enhancement of this reaction. In contrast, erythrocytes of syngeneic and allogeneic mice, rats, guinea-pigs rabbits and humans showed no or slight enhancement in CY-treated B6 mice. Maximal enhancement was observed on day 6 after CY treatment, but the reactions fell on day 7 and gradually decreased thereafter. B6 mice from specific pathogenfree colonies also showed strong reactions on day 6 after CY treatment. B6 mice demonstrated the highest reactions and C3H/He (C3H) mice were intermediate, while BALB/c mice showed very low responses. F1 hybrid (BALB/c x B6) mice showed an intermediate response as compared with the parent strains. The enhanced reactions reached their peak at 24 hr after SRBC injection and mainly consisted of macrophages and polymorphs. The enhancement could be successfully transferred to naive syngeneic mice by viable spleen cells from CY-treated mice but not by sera. The mediator cells could not bind to plastic petri dishes or a nylon-wool column, and were sensitive to anti-Thy-1.2 + C treatment . These results thus indicated that the enhancement was induced by the cell-mediated immune (CMI) mechanisms. The appearance of natural CMI reactivity to SRBC, and its role in relation to immunological reactions is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118162      PMCID: PMC1555491     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Pre-B cells: bone marrow persistence in anti-mu-suppressed mice, conversion to B lymphocytes, and recovery after destruction by cyclophosphamide.

Authors:  P D Burrows; J F Kearney; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Regulation of delayed-type hypersensitivity reactions by cyclophosphamide-sensitive T cells.

Authors:  A Schwartz; P W Askenase; R K Gershon
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

Review 3.  An analysis of the murine NK cell as to structure, function and biological relevance.

Authors:  R Kiessling; H Wigzell
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

Review 4.  Natural cell-mediated immunity.

Authors:  R B Herberman; H T Holden
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

5.  Requirement for a bacterial flora before mice generate cells capable of mediating the delayed hypersensitivity reaction to sheep red blood cells.

Authors:  T T MacDonald; P B Carter
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

6.  A-specific autoantigenic ovarian glycolipids inducing production of 'natural' anti-A antibody.

Authors:  P Arend; J Nijssen
Journal:  Nature       Date:  1977-09-15       Impact factor: 49.962

7.  Increased infiltration by monocytes in delayed type hypersensitivity site following cyclophosphamide treatment.

Authors:  G Milon; G Marchal
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

8.  Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide.

Authors:  M S Sy; S D Miller; H N Claman
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

9.  Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice.

Authors:  H Cantor; L McVay-Boudreau; J Hugenberger; K Naidorf; F W Shen; R K Gershon
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

Authors:  M Röllinghoff; A Starzinski-Powitz; K Pfizenmaier; H Wagner
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  1 in total

1.  Expression of macrophage functions in hybrids of a myeloma cell line with inflammatory macrophages: evidence for negative control mechanisms in the expression of macrophage functions.

Authors:  S Yamamoto; Y Higuchi
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.